Corporate Banner
Satellite Banner
Genomics
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

Affymetrix Announces Collaboration with Centre for Proteomic and Genomic Research (CPGR)

Published: Tuesday, November 20, 2012
Last Updated: Tuesday, November 20, 2012
Bookmark and Share
CPGR will provide gene expression and Axiom genotyping services to African researchers using GeneTitan® Multi-Channel (MC) Instrument.

The Affymetrix and CPGR partnership aims to enable high-throughput genomics research and personalized medicine projects across Africa.

The CPGR is a nonprofit organization funded by the Technology Innovation Agency (TIA), which is based on an initiative by the Department of Science and Technology (DST) whose goal is to develop the bio-economy in South Africa. According to Dr Reinhard Hiller, Managing Director of the CPGR, “The high throughput capability of GeneTitan® MC Instrument combined with customizable Axiom® Genotyping Arrays is ideal for meeting the needs of scientists in Africa whose research projects range from small pilot to large-scale discovery to focused validation studies. GeneTitan® MC Instrument expands our genomics service capabilities and will further enable CPGR to support cutting-edge translational research in Africa. Further, it allows discovery and validation of disease-related biomarkers economically – even when searching for very rare genetic variants. We expect to progress personalized medicine studies that aim to discover genetic markers specific in the African population for better diagnosis and drug treatment.”

It is a well-known fact that genetic variability of African populations is far greater than in other regions in the world. This is particularly important when considering that African populations are underrepresented in most studies on hereditary diseases and pharmacogenomics. Applying these types of genomic discoveries to clinical practices has the potential to change health and wellness of African populations.

“We are excited to partner with CPGR and see this as a significant opportunity to ensure that African populations are represented in genomics research studies leading to personalized therapies. Affymetrix is leading the way in population optimized genotyping analysis and was the first to create a genotyping array with content derived specifically from African populations,” said Chris Barbazette, VP of Commercial Operations, International Markets at Affymetrix.


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Related Content

Affymetrix, BioRealm, RUCDR Ally
Affymetrix, BioRealm, and RUCDR Infinite Biologics today announced a strategic alliance to genotype the National Institute of Drug Abuse biorepository.
Wednesday, July 08, 2015
Affymetrix Acquires Assets of Eureka Genomics
Aquisition will enable provision of high throughput and economical crop and animal genotyping.
Thursday, May 14, 2015
CollabRx, Affymetrix To Develop Analytical Tools For Integrated Clinical Cancer Panels
The overall objective of the partnership is to provide scientific knowledge for biomarker CNV profiles in cancer.
Wednesday, April 16, 2014
Affymetrix and BioDiscovery Announce Software for Analysis of Whole Genome Copy Number Data
Generated from FFPE solid tumor samples for accelerating cancer translational research.
Thursday, April 11, 2013
Affymetrix and Singapore-based Start-up PathGEN Dx Sign Partnership
Agreement for diagnostic test development for pathogen detection.
Monday, August 27, 2012
Affymetrix Announces Proposed $105 Million Offering of Convertible Senior Notes Due 2019
Company expects to grant an option to purchase up to $10 million aggregate principal amount of additional notes.
Thursday, June 21, 2012
Affymetrix Announces Research Collaboration with MGH
Collaboration and licensing agreement to validate and develop new oncology biomarker tests.
Thursday, June 07, 2012
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement for CTC Technology
Combination of ScreenCell’s isolation devices and Affymetrix’ QuantiGene® ViewRNA ISH technology enables easy, accessible, sensitive, multiplex, low-cost system to enumerate and characterize CTCs and other rare cells.
Friday, May 18, 2012
Affymetrix and ScreenCell Announce Worldwide Distribution Agreement
Affymetrix releases first circulating tumour cell platform technology for 4-color RNA-ISH.
Friday, May 18, 2012
Affymetrix and BGI Enter Strategic Collaboration
Partnership to co-develop and commercialize genomic microarrays for the agricultural community.
Friday, January 13, 2012
Affymetrix to Acquire eBioscience
Under the terms of the agreement, Affymetrix will acquire eBioscience for $330 million in cash subject to certain customary adjustments. The transaction is subject to customary closing conditions.
Wednesday, December 14, 2011
Affymetrix Releases Axiom Genome-Wide Pan-African Array
The highest genomic coverage of African and African American genomes for disease association studies.
Friday, October 21, 2011
Affymetrix Releases Data from Validated SNP Database for Design of Custom Genotyping Arrays
Validated SNPs from 1000 genomes project and custom Axiom arrays will enable the next wave of genotyping studies.
Tuesday, July 27, 2010
Affymetrix Delivers First Custom Axiom Array for Kaiser Permanente/UCSF Genotyping Project
6,000-sample pilot studies completed on Axiom catalog array with superior performance.
Tuesday, May 11, 2010
Developing Countries Sign up for Pharmacogenomics for Every Nation Initiative Using the Affymetrix DMET™ Plus Panel
IPIT at the University of North Carolina in Chapel Hill is using the company’s DMET™ Plus biomarker panel to expand PGENI.
Wednesday, October 28, 2009
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
Genetic Tug of War
Researchers have reported on a version of genetic parental control in mice that is more targeted, and subtle than canonical imprinting.
Error Correction Mechanism in Cell Division
Cell biologists have reported an advance in understanding the workings of an error correction mechanism that helps cells detect and correct mistakes in cell division early enough to prevent chromosome mis-segregation and aneuploidy, that is, having too many or too few chromosomes.
How to Become a Follicular T Helper Cell
Uncovering the signals that govern the fate of T helper cells is a big step toward improved vaccine design.
Researchers Resurrect Ancient Viruses
Researchers at Massachusetts Eye and Ear and Schepens Eye Research Institute have reconstructed an ancient virus that is highly effective at delivering gene therapies to the liver, muscle, and retina.
Cell Aging Slowed by Putting Brakes on Noisy Transcription
Experiments in yeast hint at ways to extend life of some human cells.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!